Endo Pharmaceuticals Acquires Par Pharma

According to biospace.com, Endo Pharmaceuticals acquired Par Pharma for $8.05 billion. In the article, the CEO of Endo Pharmaceuticals says: “This transaction with Par builds upon our generics growth, adding a strong portfolio of high barrier-to-entry and attractive...

Banner Year for Pharma and Biotech M&A

    Among the banner year for mergers and acquisitions that 2014 saw globally, the pharmaceutical and biotech industries emerged as leaders in new deals and 2015 looks to be no different.  Check out this article from Benzinga.com to see how the pharma and...

A Look at the Top Pharma M&A Deals of 2014

    Mergers and acquisitions of biopharma companies saw a huge increase in 2014, with the largest deal more than quadrupling the top deal of 2013, and the top 10 deals all exceeding a whopping $10 billion. Take a look at the top 10 mergers and acquisitions...